Source SEC Filings (10-K/10-Q)
Data as of Mar 31, 2026
Currency USD
FYE December
This page shows 21shares XRP ETF (TOXR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Financial health score pending refresh
We are recalculating 21shares XRP ETF's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Key Financial Metrics
Earnings & Revenue
Revenue
N/A
EBITDA
N/A
Net Income
-$36.0M
21shares XRP ETF reported -$36.0M in net income in fiscal year 2025.
EPS (Diluted)
N/A
Cash & Balance Sheet
Free Cash Flow
N/A
Cash & Debt
N/A
Dividends Per Share
N/A
Shares Outstanding
12M
21shares XRP ETF had 12M shares outstanding in fiscal year 2025.
Margins & Returns
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
-14.5%
21shares XRP ETF's ROE was -14.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.
Capital Allocation
R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A
TOXR Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$52.3M | N/A | $54.7M+169999.5% | $32K | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A |
TOXR Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|
| Total Assets | $142.2M-42.6% | $247.7M-11.5% | $280.0M | N/A | $209.5M |
| Current Assets | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $6K-81.6% | $35K-73.5% | $133K | N/A | $158K |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $142.1M-42.6% | $247.7M-11.5% | $279.9M+33.7% | $209.4M0.0% | $209.4M |
| Retained Earnings | -$99.7M-110.5% | -$47.3M-180.0% | $59.2M | N/A | -$11.3M |
TOXR Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | -36.8% | N/A | 19.6%+19.5pp | 0.0% | N/A |
| Return on Assets | -36.8% | N/A | 19.5% | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 0.000.0 | 0.000.0 | 0.00 | N/A | 0.00 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A |